The San Diego Convention Center lit its sails in purple on November 19 to honor Prematurity Awareness Month, shining a light on the global issue of premature birth. We applaud the strength of mothers everywhere and stand in solidarity with our courageous patients as they embark on motherhood. #RapidfFN #SanDiegoConventionCenter #PrematurityAwarenessMonth
Hologic, Inc.
医疗设备制造业
Marlborough，MA 242,665 位关注者
Enabling healthier lives, everywhere, every day.
关于我们
We’re an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and develop groundbreaking products and services that benefit everyone, we are especially passionate about those that advance women’s health and well-being. This allows us to be a company that prospers, grows and empowers women to experience healthier lives. None of this would be possible without the talent, skills and aspirations of our employees. Their expertise and dedication to developing and sharing more robust, science-based certainty drives our increasingly global presence, as well as a pipeline that responds to the unmet health and wellness needs of women, families and communities. What powers our growth across Breast & Skeletal Health, Diagnostic Solutions, and GYN Surgical Solutions is also what differentiates us: the exceptional and clinically proven ability of our products to detect, diagnose and treat illnesses and other health conditions earlier and better. This clinical superiority creates high expectations, which we fulfill by always challenging ourselves to improve health through better technology, education and market access. Our goal is to minimize doubt and maximize the confidence our customers and their patients have in their decisions and diagnoses. We work toward this goal every day, always aware that in an increasingly complex and competitive global environment, we must continually earn the trust of our customers and their patients. By focusing on women’s health while still delivering health benefits to everyone, we are setting a new standard of excellence that is strengthened by purpose, driven by passion and brought to life by our promise of more certain early detection and better health outcomes. To view our community guidelines, visit: www.hologic.com/social-media
- 网站
-
https://www.hologic.com
Hologic, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 5,001-10,000 人
- 总部
- Marlborough，MA
- 类型
- 上市公司
- 创立
- 1985
- 领域
- Breast & Skeletal Health、Diagnostic、GYN Surgical Solutions和Medical Aesthetics
地点
Hologic, Inc.员工
动态
-
“It felt like my stomach was full of rocks.” Nearly 10 years after she learned she had a uterine fibroid, a Louisville woman has found relief with the help of our Acessa? procedure. Read her story: https://bit.ly/3MpyjOR #Hologic #WomensHealth #Healthcare
-
-
Last week, we sponsored a roundtable, The ‘New Alliances: Building Collaboration in Cervical Cancer,’ which brought together over 50 influential stakeholders in #cervical cancer to address declining cervical cancer screening participation. Attendees, including researchers, policymakers, and patient advocacy groups (PAGs), concluded that novel, collaborative thinking is needed to develop new screening strategies, with the commitment to scale up effective interventions to inform local and national action plans as an urgent priority. The unique value that PAGs bring to collaborations with researchers and policymakers working to stop the decline in cervical cancer screening participation must be recognized. Thank you to Athena Lamnisos and Matejka Rebolj, our Co-Chairs, and our inspiring speakers Jane Rigney, Mairead O'Connor, PhD, Carmen Wyton, @Tóth Icó, Ody Neisingh, Martin Hunt and Dr. Alison Wiggans
-
-
?? The RSNA scientific program is live, and we're thrilled to share details about two must-attend presentations by leading experts in breast imaging. Mark your calendars! ???Dec 1, 1:00-2:00 PM CST Title:?Advances in digital breast tomosynthesis acquisition technologies Presenter:?Dr. Andrew Maidment, Penn Andrew Maidment will explore the latest advancements in digital breast tomosynthesis, focusing on innovative acquisition technologies. ???Dec 3, 9:00-9:30 AM CST Title:?Performance of a digital breast tomosynthesis AI detection algorithm in common US racial/ethnic groups Presenter:?Dr. Sarah Friedewald, Northwestern Sally Friedewald, MD will discuss the performance of #GeniusAIDetection 2.0 across different racial/ethnic groups, shedding light on its effectiveness in different populations. Don't miss these insightful sessions that promise to advance our understanding and capabilities in breast imaging! #RSNA2024 #BreastImaging #Radiology
-
-
We're leading the way in medical innovation by integrating artificial intelligence (AI) for breast cancer screening. Our Genius AI Detection software helps radiologists Identify potential cancers with high accuracy. To gain deeper insights into our vision for AI in breast cancer screening, watch our CEO, Steve MacMillan, discuss our AI advancements in his interview on CNBC Squawk Box. https://ow.ly/z5UF50U0IrA
-
-
In the U.S., 3.9 million surgeries1 are performed on children annually. That’s why on World Children’s Day, and every day, we recognize our smallest patients deserve big outcomes. Hologic’s CoolSeal? Mini Sealer is precisely designed and indicated for pediatric surgery, equipping pediatric surgeons around the globe with minimally invasive surgical options for their smallest patients. Learn more: https://ow.ly/vAZS50UawTr #Hologic #PediatricHealth #Healthcare #WorldChildrensDay
-
-
Heger RAJAH joined Hologic after witnessing the company's impact on patients. Fourteen and a half years later, that same impact keeps her here and fuels her passion for interacting with customers and improving patient care. #WhyHologic
-
Get Ready for Another Big Reveal at RSNA 2024! ?? Join us on Monday, December 2nd at 1:00 PM CT at our booth for an exclusive reveal of "Driven to Detect," our groundbreaking AI assistant set to revolutionize breast screening. Don't miss out—be among the first to witness the future of breast health! https://heyor.ca/YJmgpf
-
-
Cancer treatment is typically guided by where the original tumor began. But what happens when it’s unclear where in the body the cancer started? A new study shows that our CancerTYPE ID? assay could improve the way we treat cancer of unknown primary (CUP), a group of cancers that has historically been very challenging to treat. The test identified tumor types in 92.5% of cases. Identifying tumor type, along with comprehensive genomic profiling, unlocks the possibility for more personalized, site-specific therapies for patients with CUP — and as a result, better clinical outcomes. Learn more about the study: https://ow.ly/Tpmj50U8vOu #PersonalizedMedicine #PrecisionMedicine #Oncology